Literature DB >> 5524216

The infleunce of hypersensitivity on the pathogenesis of ocular toxoplasmosis.

G R O Connor.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5524216      PMCID： PMC1310389     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  45 in total

1.  NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.

Authors:  A W CHEEVER; M P VALSAMIS; A S RABSON
Journal:  N Engl J Med       Date:  1965-01-07       Impact factor: 91.245

2.  A TISSUE CULTURE METHOD FOR TITRATION OF INFECTIVITY AND DETERMINATION OF GROWTH RATE OF TOXOPLASMA GONDII. 1.

Authors:  E LYCKE; E LUND
Journal:  Acta Pathol Microbiol Scand       Date:  1964

3.  [DETECTION OF TOXOPLASMA IN A CASE OF SERUM-NEGATIVE CHORIORETINITIS].

Authors:  A FRANCESCHETTI; E ENGELBRECHT
Journal:  Ophthalmologica       Date:  1964       Impact factor: 3.250

4.  Pathogenesis of toxoplasmosis with a consideration of cyst rupture in Besnoitia infection.

Authors:  J K FRENKEL
Journal:  Surv Ophthalmol       Date:  1961-12       Impact factor: 6.048

5.  Production in mice of large volumes of ascites fluid containing antibodies.

Authors:  J MUNOZ
Journal:  Proc Soc Exp Biol Med       Date:  1957 Aug-Sep

6.  Disseminated cytomegalic inclusion disease and disseminated toxoplasmosis in an adult with myeloid metaplasia; report of a case.

Authors:  F A HEMSATH; H PINKERTON
Journal:  Am J Clin Pathol       Date:  1956-01       Impact factor: 2.493

7.  Therapy of ocular toxoplasmosis.

Authors:  I H LEOPOLD
Journal:  Surv Ophthalmol       Date:  1961-12       Impact factor: 6.048

8.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

9.  [Physico-chemical and biological characteristics of toxotoxin].

Authors:  O Zardi; G Giorgi; A Panà; V Monaco
Journal:  Recenti Prog Med       Date:  1967-03

10.  Cerebral toxoplasmosis in multiple myeloma.

Authors:  A Theologides; K Osterberg; B J Kennedy
Journal:  Ann Intern Med       Date:  1966-05       Impact factor: 25.391
View more
  7 in total

1.  Localisation of macrophage lysosomal enzyme in experimental toxoplasma retinitis.

Authors:  M O Yoshizumi
Journal:  Br J Ophthalmol       Date:  1977-06       Impact factor: 4.638

2.  Manifestations and management of ocular toxoplasmosis.

Authors:  G R O'Connor
Journal:  Bull N Y Acad Med       Date:  1974-02

3.  Retinal vascular involvement in acute toxoplasmic retinochoroiditis.

Authors:  P Theodossiadis; S Kokolakis; I Ladas; A C Kollia; D Chatzoulis; G Theodossiadis
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

4.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

5.  A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis).

Authors:  Gary N Holland
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 6.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03

Review 7.  Ocular disease in AIDS.

Authors:  I Kuo; N A Rao
Journal:  Springer Semin Immunopathol       Date:  1999
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.